NorthWest Biotherapeutics Inc (NWBO)

[Basin Street Blues]

Flip , something i’m very unclear on is we know there was one SAP ( revised ). LP stated she would not DL till she had buy-in from all 4 regulators . We know for sure we have had buy-in from two of those and that alone guarantees a degree of success and as I said earlier. that’s got $5 day one on TLD written all over it .

So what if she never got buyin from the FDA and Canada would she have never locked the data because that’s what she very clearly said in the public domain , and then what ......?

I think the FDA didn’t respond and that’s supported by the fact NWBO have not updated clinicaltrial.gov and i’m suggesting that LP said lock and start the analysis anyway because what she said re all 4 buyins before locking
is simply and utterly ridiculous , or am I missing something ??

Then come TLD day , of course we can say ‘ met endpoints 1 ,2 ,3. etc etc ‘ because we did in the UK and EU
and then what , another PR. saying we failed US endpoints ?

Also you said to me earlier that no response from FDA could be tacit approval as such , but at what stage will the company know ? I believed from first hand information that we have had a long term good relationship with the FDA and of course its not in the FDA’s interest or those they serve to be obstinate .

I’d really appreciate your insight on the above as i’m honestly confused about these points

Thanks

(Of course update FDA site and we open at $3 same day and all is forgiven ...)